CRDL
Cardiol Therapeutics Inc.
$1.12
$0.00(0.00%)
63
Overall
--
Value
63
Tech
--
Quality
Market Cap
$89.35M
Volume
568.53K
52W Range
$0.77 - $2.44
Target Price
$8.80
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | -- | -- | $78.8K | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | $78.8K | -- | -- | -- | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $7.5M | $14.1M | $20.7M | $38.7M | -- | $29.8M | $40.3M | ||
| Research & Development | $1.5M | $3.5M | $10.6M | $10.9M | -- | $14.2M | $14.0M | ||
| Research Expense | -- | -- | -- | -- | -- | -- | $14.0M | ||
| Selling, General & Administrative | $5.9M | $10.4M | $10.1M | $27.9M | -- | $15.6M | -- | ||
| General & Administrative Expenses | $5.9M | $10.4M | $10.1M | $27.9M | -- | $15.6M | -- | ||
| Salaries & Wages | $3.0M | $5.1M | $4.9M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $91.5K | $150.6K | $229.5K | -- | -- | -- | -- | ||
| Depreciation & Amortization | $91.5K | $150.6K | $229.5K | -- | -- | -- | -- | ||
| Amortization | $84.4K | $84.4K | $84.4K | -- | -- | -- | -- | ||
| Securities Amortization | $663.4K | -- | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | -- | -- | $15.6M | $26.3M | ||
| OPERATING INCOME | |||||||||
| Operating income | $-7.5M | $-14.1M | $-20.7M | $-38.7M | -- | $-29.8M | $-40.3M | ||
| EBITDA | $-15.1M | $-13.5M | $-20.5M | $-38.4M | $-41.1M | -- | $-36.3M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $663.4K | $621 | -- | -- | -- | -- | -- | ||
| Intinc | $103.3K | $245.4K | $76.6K | $106.0K | -- | $2.0M | $1.2M | ||
| Net Non-Operating Interest Income/Expense | $560.1K | $-244.8K | $-76.6K | $-106.0K | -- | $2.0M | $1.2M | ||
| Gain on Sale of Securities | $-7.8M | $-99.8K | $-34.5K | $6.8M | -- | -- | -- | ||
| Other Income/Expense | $-7.8M | $198.9K | $-27.1K | $6.9M | -- | $-331.5K | $-266.4K | ||
| Other Special Charges | -- | -- | -- | -- | -- | $149.7K | $28.2K | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-15.2M | $-13.7M | $-20.6M | $-31.6M | $-36.5M | -- | $-36.7M | ||
| Pre-Tax Income | $-15.9M | $-13.7M | $-20.6M | $-31.6M | -- | $-26.7M | $-36.7M | ||
| NET INCOME | |||||||||
| Net Income | $-15.9M | $-13.7M | $-20.6M | $-31.6M | -- | $-26.7M | $-36.7M | ||
| Net Income (Continuing Operations) | $-15.9M | $-13.7M | $-20.6M | $-31.6M | -- | $-26.7M | $-36.7M | ||
| Net Income (Discontinued Operations) | $-15.9M | $-13.7M | $-20.6M | $-31.6M | -- | $-26.7M | $-36.7M | ||
| Net Income (Common Stockholders) | $-15.9M | $-13.7M | $-20.6M | $-31.6M | -- | $-26.7M | $-36.7M | ||
| Normalized Income | $-11.7M | $-10.1M | $-15.2M | $-23.3M | $-26.8M | -- | $-36.3M | ||
| TOTALS | |||||||||
| Total Expenses | $-7.5M | $-14.1M | $-20.7M | $-38.7M | -- | -- | $40.3M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $15.4M | $25.8M | $29.9M | $43.2M | -- | $64.5M | $71.6M | ||
| Average Shares Outstanding (Diluted) | $15.4M | $25.8M | $29.9M | $43.2M | -- | $64.5M | $71.6M | ||
| Shares Outstanding | $22.7M | $25.9M | $32.9M | $61.0M | $83.7M | $83.7M | $82.6M | ||
| Basic EPS | $-1.03 | $-0.53 | $-0.69 | $-0.73 | -- | $-0.44 | $-0.51 | ||
| Basic EPS (Continuing Operations) | $-1.03 | $-0.53 | $-0.69 | $-0.73 | -- | $-0.44 | $-0.51 | ||
| Diluted EPS | $-1.03 | $-0.53 | $-0.69 | $-0.73 | -- | $-0.44 | $-0.51 | ||
| Diluted EPS (Continuing Operations) | $-1.03 | $-0.53 | $-0.69 | $-0.73 | -- | $-0.44 | $-0.51 | ||
| OTHER METRICS | |||||||||
| Other Gand A | $5.9M | $10.4M | $10.1M | $27.9M | -- | $15.6M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRDL | $1.12 | 0% | 568.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cardiol Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW